首页> 外文期刊>Stem cells international >Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats
【24h】

Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats

机译:癌症干细胞和MSCs源自癌症干细胞的潜在效应对大鼠植入HCC的进展

获取原文
获取原文并翻译 | 示例
           

摘要

Cross talk, mediated by exosomes, between normal stem cells and cancer stem cells (CSCs) in the tumor microenvironment has been given less attention so far. In addition, no publications are available in the literature that address the in vivo impact of exosomes derived from CSCs and mesenchymal stem cells (MSCs) on progression of long-term hepatocellular carcinoma (HCC). Herein, we hypothesized that transfer of exosomes among the cells in the HCC microenvironment could either induce or inhibit tumor growth and metastasis depending on their source. To check this hypothesis, we investigated the effect of exosomes coming from two different stem cell populations, hepatic CSCs and bone marrow (BM) MSCs, on progression of long-term DEN-induced HCC in rats and the involved underlying mechanisms. CSCs-exosomes induced a significant increase in liver relative weight and serum levels of cancer markers (AFP and GGT) and liver enzymes (ALT, AST, and ALP), intensive immunostaining for the HCC marker GST-P, and an increased number and area of tumor nodules as compared to HCC rats injected by PBS. CSCs-exosomes also decreased apoptosis (marked by downregulation of Bax and p53 and upregulation of Bcl2, and increased immunostaining of PCNA), increased angiogenetic activity (revealed by upregulation of VEGF), enhanced metastasis and invasiveness (indicated by upregulation of P13K and ERK proteins and their downstream target MMP9 and downregulation of TIMP1), and induced epithelial mesenchymal transition (marked by increased serum and hepatic level of TGF beta 1 mRNA and protein). Notably, CSCs-exosomes also elevated HCC exosomal microRNA (miR) 21, exosomal long noncoding (Inc) RNA Tuc339, lncHEIH, and the HCC lncHOTAIR and decreased liver miR122 and HCC miRs (miR148a, miR16, and miR125b). All these cellular, functional, and molecular changes were reversed following injection of BM-MSCs-exosomes. However, both CSCs- and MSCs-exosomes failed to change the elevated oxidative stress or the inhibited antioxidant activities induced by HCC. Collectively, our results revealed a tumor stimulatory effect (induction of tumor growth, progression, and metastasis) for exosomes derived from CSCs and an inhibitory effect for exosomes derived from MSCs. These results provide valuable insight on the effect of CSCs- and MSCs-exosomes on HCC growth and progression in vivo, which may be helpful to understand the mechanism of HCC development.
机译:到目前为止,肿瘤微环境中的正常干细胞和癌症干细胞(CSCs)之间介导的交叉谈话,肿瘤微环境中的癌症和癌症干细胞(CSC)。此外,文献中没有任何出版物可以解决衍生自CSC和间充质干细胞(MSCs)的外来源性的体内影响,在长期肝细胞癌(HCC)的进展中。在此,我们假设HCC微环境中细胞中外来的转移可以诱导或抑制肿瘤生长和转移,这取决于它们的来源。为了检查这一假设,我们研究了外来源来自两种不同的干细胞群,肝CSC和骨髓(BM)MSC的效果,在大鼠和所涉及的潜在机制中进行长期植物诱导的HCC的进展。 CSCS-Exosomes诱导肝脏相对重量和血清癌症标记物(AFP和GGT)和肝酶(ALT,AST和ALP),对HCC标记物GST-P的强烈免疫抑制的显着增加,以及数量和面积增加与由PBS注入的HCC大鼠相比的肿瘤结节。 CSCs-Exosomes还降低了凋亡(由BAX和P53的下调标记,BCL 2的上调,并且PCNA的免疫染色增加),增加血管生成活性(通过VEGF的上调揭示),增强的转移和侵袭性(通过P13K和ERK蛋白表明表明及其下游靶标mmp9和timp1的下调),并诱导上皮间充质转换(由增加的血清和tgfβ1mRNA和蛋白质的肝水平标记)。值得注意的是,CSCs-Exosomes还升高了HCC外泌体microRNA(MIR)21,外泌体长Noncoding(Inc)RCN TCN 339,LNCheIH和HCC LnCrair和肝脏miR122和HCC miR(miR148a,mir16和mir125b)。在注射BM-MSCs-Exosomes后,所有这些细胞,功能和分子变化都反转。然而,CSCS和MSCs-Exosomes都未改变HCC诱导的氧化应激或抑制的抗氧化活性。统称,我们的结果揭示了肿瘤刺激作用(诱导肿瘤生长,进展和转移),用于源自CSC的外泌体和衍生自MSCs的外索物的抑制作用。这些结果提供了有价值的洞察CSCS-和MSCs-Exosomes对HCC生长和体内进展的影响,这可能有助于了解HCC开发机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号